Breast Cancer Treatment with Gentiana robusta
Author Information
Author(s): Xiong Bo, Zhang Xinxin, Sangji Dongzhi, Ni Lianghong, Fan Mingjie, Fan Beibei
Primary Institution: Shanghai University of Traditional Chinese Medicine
Hypothesis
This study investigates the potential treatment of breast cancer utilizing Gentiana robusta through an integrated approach involving network pharmacology, molecular docking, and molecular dynamics simulation.
Conclusion
The study reveals that components of Gentiana robusta can effectively interact with key target genes involved in breast cancer treatment.
Supporting Evidence
- Key target genes such as IL-6, TP53, and EGFR were identified as significant in breast cancer treatment.
- Network pharmacology highlighted the involvement of Gentiana robusta in cancer signaling pathways.
- Molecular docking showed strong interactions between Gentiana robusta components and target proteins.
Takeaway
Researchers found that a plant called Gentiana robusta might help treat breast cancer by working on important genes in the body.
Methodology
The study used network pharmacology, molecular docking, and molecular dynamics simulations to analyze the effects of Gentiana robusta on breast cancer.
Limitations
Further experimental research is needed to validate the computational findings of Gentiana robusta.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website